摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(2-amino-5-chloro-thiazol-4-yl)-acetic acid methyl ester | 1052722-35-6

中文名称
——
中文别名
——
英文名称
(2-amino-5-chloro-thiazol-4-yl)-acetic acid methyl ester
英文别名
Methyl 2-(2-amino-5-chloro-1,3-thiazol-4-YL)acetate;methyl 2-(2-amino-5-chloro-1,3-thiazol-4-yl)acetate
(2-amino-5-chloro-thiazol-4-yl)-acetic acid methyl ester化学式
CAS
1052722-35-6
化学式
C6H7ClN2O2S
mdl
——
分子量
206.653
InChiKey
UEFFWVSYJBYHSD-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.4
  • 重原子数:
    12
  • 可旋转键数:
    3
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.33
  • 拓扑面积:
    93.4
  • 氢给体数:
    1
  • 氢受体数:
    5

文献信息

  • ACC INHIBITORS AND USES THEREOF
    申请人:Nimbus Apollo, Inc.
    公开号:US20130123231A1
    公开(公告)日:2013-05-16
    The present invention provides compounds useful as inhibitors of Acetyl CoA Carboxylase (ACC), compositions thereof, and methods of using the same.
    本发明提供了作为乙酰辅酶A羧化酶(ACC)抑制剂的化合物,以及其组合物和使用方法。
  • [EN] ACC INHIBITORS AND USES THEREOF<br/>[FR] INHIBITEURS DE L'ACC ET UTILISATIONS ASSOCIÉES
    申请人:NIMBUS APOLLO INC
    公开号:WO2013071169A1
    公开(公告)日:2013-05-16
    The present invention provides compounds, specifically thienopyrimidine derivatives, useful as inhibitors of Acetyl CoA Carboxylase (ACC), pharmaceutical compositions thereof, and methods of using the same for treating ACC-mediated disorders such as obesity, dyslipidemia, hyperiipidemia, fungal, parasitic or bacterial infections in a subject. The invention further provides a method of inhibiting ACC in a plant comprising contacting the plant with the inhibitor compound.
    本发明提供一种化合物,具体地是噻吩嘧啶生物,可用作乙酰辅酶A羧化酶(ACC)的抑制剂,其制药组合物以及使用相同的方法,用于治疗ACC介导的疾病,例如肥胖症、血脂异常、高血脂症、真菌、寄生虫或细菌感染。本发明还提供一种抑制植物中ACC的方法,包括将植物与抑制剂化合物接触。
  • 2,2,2-TRI-SUBSTITUTED ACETAMIDE DERIVATIVES AS GLUCOKINASE ACTIVATORS, THEIR PROCESS AND PHARMACEUTICAL APPLICATION
    申请人:Mookhtiar Kasim A.
    公开号:US20100144772A1
    公开(公告)日:2010-06-10
    Compounds of the present disclosure are 2,2,2-tri-substituted acetamide derivatives of formula (I), its polymorphs, stereoisomers, prodrugs, solvates, pharmaceutically acceptable salts and formulations thereof, useful as Glucokinase activator. Processes of their preparation are also described in the disclosure. The disclosure also describes method to characterize partial glucokinase activators.
    本公开涉及的化合物是式(I)的2,2,2-三取代乙酰胺衍生物,其多晶形态、立体异构体、前药、溶剂化物、药学上可接受的盐和制剂,可用作葡萄糖激酶激活剂。公开还描述了它们的制备过程。公开还描述了表征部分葡萄糖激酶激活剂的方法。
  • 2,2,2-tri-substituted acetamide derivatives as glucokinase activators, their process and pharmaceutical application
    申请人:Mookhtiar Kasim A.
    公开号:US08940900B2
    公开(公告)日:2015-01-27
    Compounds of the present disclosure are 2,2,2-tri-substituted acetamide derivatives of formula (I), its polymorphs, stereoisomers, prodrugs, solvates, pharmaceutically acceptable salts and formulations thereof, useful as Glucokinase activator. Processes of their preparation are also described in the disclosure. The disclosure also describes method to characterize partial glucokinase activators.
    本公开涉及的化合物是式(I)的2,2,2-三取代乙酰胺衍生物,其多晶形态、立体异构体、前药、溶剂化物、药学上可接受的盐和制剂,可用作葡萄糖激酶激活剂。本公开还描述了它们的制备方法。本公开还描述了表征部分葡萄糖激酶激活剂的方法。
  • US8940900B2
    申请人:——
    公开号:US8940900B2
    公开(公告)日:2015-01-27
查看更多